Modulation of integrin antagonist signaling by ligand binding of the heparin-binding domain of vitronectin to the αVβ3 integrin

Journal of Cellular Biochemistry

Volumn 105, Issue 2, 2008, Pages 437-446

  Maile, Laura A ^a   Aday, Ariel W ^a   Busby, Walker H ^a   Sanghani, Ravi ^a   Veluvolu, Umadevi ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Echistatin; Integrin; Vitronectin

Indexed keywords

CALPAIN; DISINTEGRIN; ECHISTATIN; HEPARIN; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; VITRONECTIN; VITRONECTIN RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME INHIBITION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; DISINTEGRINS; HEPARIN; INTEGRIN ALPHAVBETA3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MYOCYTES, SMOOTH MUSCLE; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SWINE; VITRONECTIN;

EID: 54849406563     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21841     Document Type: Article

References (39)

1. Aplin AE, Howe A, Alahari SK, Juliano RL. 1998. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 50:197-263.
2. Aplin AE, Howe AK, Juliano RL. 1999. Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol 11:737-744.
3. Bialkowska K, Kulkarni S, Du X, Goll DE, Saido TC, Fox JE. 2000. Evidence that beta3 integrin-induced Rac activation involves the calpain-dependent formation of integrin clusters that are distinct from the focal complexes and focal adhesions that form as Rac and RhoA become active. J Cell Biol 151:685-696.
4. Blobel CP, White JM. 1992. Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr Opin Cell Biol 4:760-765.
5. Brassard DL, Maxwell E, Malkowski M, Nagabhushan TL, Kumar CC, Armstrong L. 1999. Integrin alpha(v)beta(3)-mediated activation of apoptosis. Exp Cell Res 251:33-45.
6. Clemmons DR, Horvitz G, Engleman W, Nichols T, Moralez A, Nickols GA. 1999. Synthetic alphaVbeta3 antagonists inhibit insulin-like growth factor-I- stimulated smooth muscle cell migration and replication. Endocrinology 140:4616-4621.
7. Cooray P, Yuan Y, Schoenwaelder SM, Mitchell CA, Salem HH, Jackson SP. 1996. Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain. Biochem J 318(Pt 1):41-47.
8. Du X, Saido TC, Tsubuki S, Indig FE, Williams MJ, Ginsberg MH. 1995. Calpain cleavage of the cytoplasmic domain of the integrin beta 3 subunit. J. Biol Chem 270:26146-26151.
9. Fox JE, Goll DE, Reynolds CC, Phillips DR. 1985. Identification of two proteins (actin-binding protein and P235) that are hydrolyzed by endogenous Ca2R-dependent protease during platelet aggregation. J. Biol Chem 260:1060-1066.
10. Gan ZR, Gould RJ, Jacobs JW, Friedman PA, Polokoff MA. 1988. Echistatin. A. potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem 263:19827-19832.
11. Gilmore AP, Romer LH. 1996. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 7:1209-1224.
12. Glading A, Lauffenburger DA, Wells A. 2002. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 12:46-54.
13. Gockerman A, Prevette T, Jones JI, Clemmons DR. 1995. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology 136:4168-4173.
14. Goll DE, Thompson VF, Li H, Wei W, Cong J. 2003. The calpain system. Physiol Rev 83:731-801.
15. Jones JI, Prevette T, Gockerman A, Clemmons DR. 1996. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci U S A 93:2482-2487.
16. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL. 1992. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J. Biol Chem 267:23439-23442.
17. Kurosaki T, Takata M, Yamanashi Y, Inazu T, Taniguchi T, Yamamoto T, Yamamura H. 1994. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J. Exp Med 179:1725-1729.
18. Ling Y, Maile LA, Clemmons DR. 2003. Tyrosine Phosphorylation of the {beta}3-Subunit of the {alpha}V{beta}3 Integrin Is Required for Membrane Association of the Tyrosine Phosphatase SHP-2 and Its Further Recruitment to the Insulin-Like Growth Factor I Receptor. Mol Endocrinol 17:1824-1833.
19. Ling Y, Maile LA, Badley-Clarke J, Clemmons DR. 2005. DOK1 mediates SHP-2 binding to the alphaVbeta3 integrin and thereby regulates insulin-like growth factor I signaling in cultured vascular smooth muscle cells. J. Biol Chem 280:3151-3158.
20. Maile LA, Clemmons DR. 2002. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor. Endocr J 143:4259-4264.
21. Maile LA, Badley-Clarke J, Clemmons DR. 2001. Structural analysis of the role of the beta 3 subunit of the alpha V beta 3 integrin in IGF-I signaling. J Cell Sci 114:1417-1425.
22. Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Clemmons DR. 2006a. IGF-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the {beta}3 subunit of {alpha}V{beta}3. Mol Endocrinol 20:881-892.
23. Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Ling Y, Clemmons DR. 2006b. The heparin-binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling. Mol Endocrinol 20:405-411.
24. Manes S, Mira E, Gomez-Mouton C, Zhao ZJ, Lacalle RA, Martinez-A C. 1999. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase regulation of cell motility. Mol Cell Biol 4:3125-3135.
25. Marcinkiewicz C, Vijay-Kumar S, McLane MA, Niewiarowski S. 1997. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site. Blood 90:1565-1575.
26. Meredith J Jr, Mu Z, Saido T, Du X. 1998. Cleavage of the cytoplasmic domain of the integrin beta3 subunit during endothelial cell apoptosis. J Biol Chem 273:19525-19531.
27. Niewiarowski S, McLane MA, Kloczewiak M, Stewart GJ. 1994. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol 31:289-300.
28. Perrin BJ, Huttenlocher A. 2002. Calpain. Int J Biochem Cell Biol 34:722-725.
29. Pfaff M, Du X, Ginsberg MH. 1999. Calpain cleavage of integrin beta cytoplasmic domains. FEBS Lett 460:17-22.
30. Ritter MR, Zhou Q, Markland FS Jr. 2000. Contortrostatin, a snake venom disintegrin, induces alphavbeta3-mediated tyrosine phosphorylation of CAS and FAK in tumor cells. J. Cell Biochem 79:28-37.
31. Ritter MR, Zhou Q, Markland FS Jr. 2001. Contortrostatin, a homodimeric disintegrin, actively disrupts focal adhesion and cytoskeletal structure and inhibits cell motility through a novel mechanism. Cell Commun Adhes 8:71-86.
32. Saito Y, Saido TC, Sano K, Kawashima S. 1994. The calpain-calpastatin system is regulated differently during human neuroblastoma cell differentiation to Schwannian and neuronal cells. FEBS Lett 353:327-331.
33. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT. 1994. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 14:1680-1688.
34. Schoenwaelder SM, Kulkarni S, Salem HH, Imajoh-Ohmi S, Yamao-Harigaya W, Saido TC, Jackson SP. 1997. Distinct substrate specificities and functional roles for the 78- and 76-kDa forms of mu-calpain in human platelets. J Biol Chem 272:24876-24884.
35. Sieg DJ, Hauck CR, Schlaepfer DD. 1999. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 112(Pt 16):2677-2691.
36. Suzuki S, Pierschbacher MD, Hayman EG, Nguyen K, Ohgren Y, Ruoslahti E. 1984. Domain structure of vitronectin. Alignment of active sites. J Biol Chem 259:15307-15314.
37. Xiong JP, Stehle T, Diefenbach B, Zhang R, Dunker R, Scott DL, Joachimiak A, Goodman SL, Arnaout MA. 2001. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 294:339-345.
38. Yoneda A, Kojima K, Matsumoto I, Yamamoto K, Ogawa H. 1996. Porcine vitronectin, the most compact form of single-chain vitronectin: the smallest molecular mass among vitronectins was ascribed to deletion and substitution of base pairs, and proteolytic trimming of the peptide. J Biochem (Tokyo) 120:954-960.
39. Zheng B, Clemmons DR. 1998. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin- like growth factor I signaling in vascular smooth muscle cells. Proc Natl Acad Sci USA 95:11217-11222.